OverviewSuggest Edit

Xtant Medical develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company's products serve the specialized needs of orthopedic and neurological surgeons, including ortho biologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

TypePublic
Founded2006
HQBelgrade, US
Websitextantmedical.com
Employee Ratings2.1

Latest Updates

Employees (est.) (Sep 2017)253
Revenue (FY, 2018)$72.2 M(-12%)
Share Price (May 2019)$3.5 (+14%)

Key People/Management at Xtant Medical

Kevin Brandt

Kevin Brandt

Sr. Vice President and Chief Commercialization Officer
Ron Berlin

Ron Berlin

Chief Operations Officer
Anthony DeFalco

Anthony DeFalco

Vice President of Product Development and Operations
Show more

Xtant Medical Office Locations

Xtant Medical has offices in Belgrade and Miamisburg
Belgrade, US (HQ)
664 Cruiser Ln
Miamisburg, US
452 Alexandersville Rd
Show all (2)

Xtant Medical Financials and Metrics

Xtant Medical Revenue

Embed Graph
View revenue for all periods
Xtant Medical's revenue was reported to be $72.20 m in FY, 2018
USD

Revenue (Q1, 2019)

16.7m

Gross profit (Q1, 2019)

10.8m

Gross profit margin (Q1, 2019), %

64.6%

Net income (Q1, 2019)

(2.8m)

EBIT (Q1, 2019)

(668.0k)

Market capitalization (22-May-2019)

45.6m

Closing stock price (22-May-2019)

3.5

Cash (31-Mar-2019)

7.1m
Xtant Medical's current market capitalization is $45.6 m.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

33.1m35.3m59.3m90.0m82.6m72.2m

Revenue growth, %

7%68%52%

Cost of goods sold

14.2m13.0m20.3m27.7m32.5m28.7m

Gross profit

18.9m22.3m39.1m62.3m50.1m43.5m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Revenue

7.9m8.9m8.9m8.5m9.5m9.9m17.7m21.0m21.5m23.1m22.1m21.4m19.8m17.9m18.7m17.3m16.7m

Cost of goods sold

3.5m3.4m6.0m6.9m6.8m7.1m6.6m7.9m8.4m5.7m6.3m5.7m5.9m

Gross profit

6.0m6.5m11.7m14.1m14.7m16.0m15.5m13.5m11.4m12.2m12.5m11.5m10.8m

Gross profit Margin, %

63%66%66%67%69%69%70%63%57%68%67%67%65%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

3.0m4.5m6.4m2.6m2.9m6.8m

Accounts Receivable

Inventories

10.8m22.7m17.3m

Current Assets

19.2m19.1m45.4m49.0m39.5m34.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019

Cash

3.4m4.8m3.0m7.0m2.9m2.0m8.0m4.7m2.2m1.4m2.5m1.7m2.1m6.2m6.0m5.1m7.1m

Accounts Receivable

4.1m

Inventories

13.2m10.5m10.5m11.1m9.7m9.4m22.0m1.7m16.5m

Current Assets

21.8m21.8m19.4m23.2m19.0m18.0m44.4m44.7m43.7m45.8m46.8m43.3m40.7m40.1m39.7m37.9m33.6m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(12.7m)(10.5m)(2.2m)(19.5m)(52.4m)(70.1m)

Depreciation and Amortization

753.5k271.7k4.9m7.2m8.4m6.6m

Inventories

747.7k(17.4k)(545.7k)(4.1m)2.1m40.0k

Accounts Payable

(1.0m)715.7k644.1k319.1k(1.6m)(3.0m)
USDY, 2019

Financial Leverage

-1.2 x
Show all financial metrics

Xtant Medical News and Updates

Xtant Medical Announces First Quarter 2019 Financial Results

BELGRADE, Mont., May 15, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2019.

Xtant Medical Receives Noncompliance Notice from NYSE American

BELGRADE, Mont., April 05, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced receipt of notification from the NYSE American that the Company is not in…

Xtant Medical Announces Fourth Quarter and 2018 Financial Results

BELGRADE, Mont., April 01, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the fourth quarter and year ended Dece…

Xtant Medical Announces Amendments and Extension of Credit Facility

BELGRADE, Mont., April 01, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it has executed the Second Amended and Restated Credit Agreement wit…

Xtant Medical to Issue Fourth Quarter and Full Year 2018 Financial Results on April 1, 2019

BELGRADE, Mont., March 28, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and ful…

Xtant Medical Announces Appointment of New Senior Sales Leaders

BELGRADE, MT, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the recent additions of five senior sales executives: Dana Lyons, Vice Presi…
Show more

Xtant Medical Blogs

Xtant Medical to Issue First Quarter 2019 Financial Results on May 15, 2019

BELGRADE, Mont. , May 08, 2019 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended The po…

Xtant Medical Announces Appointment of Chief Operations Officer

BELGRADE, MT , Jan. 11, 2019 (GLOBE NEWSWIRE) — Xtant Medical Holdings , Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Ronald Berlin as Vice President & Chief Operations The …

Xtant Medical Announces Appointment of Chief Financial Officer

BELGRADE, MT, Aug. 20, 2018 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development and commercialization of regenerative medicine products and medical devices, today announced the appointment of Kathie Lenzen as chief financial officer, effective August 20…

Xtant Medical Announces Second Quarter 2018 Financial Results

BELGRADE, MT, Aug. 07, 2018 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial and operating results for the second quarter ended June 30, 2018. Summary of Second Quarter 2…

Xtant Medical Frequently Asked Questions

  • When was Xtant Medical founded?

    Xtant Medical was founded in 2006.

  • Who are Xtant Medical key executives?

    Xtant Medical's key executives are Kevin Brandt, Ron Berlin and Anthony DeFalco.

  • How many employees does Xtant Medical have?

    Xtant Medical has 253 employees.

  • What is Xtant Medical revenue?

    Latest Xtant Medical annual revenue is $72.2 m.

  • What is Xtant Medical revenue per employee?

    Latest Xtant Medical revenue per employee is $285.4 k.

  • Who are Xtant Medical competitors?

    Competitors of Xtant Medical include Deltex Medical, Encision and Bovie Medical.

  • Where is Xtant Medical headquarters?

    Xtant Medical headquarters is located at 664 Cruiser Ln, Belgrade.

  • Where are Xtant Medical offices?

    Xtant Medical has offices in Belgrade and Miamisburg.

  • How many offices does Xtant Medical have?

    Xtant Medical has 2 offices.